Seizert Capital Partners’s Pediatrix Medical MD Stock Holding History

Seizert Capital Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$502K	Buy	19,809 +10	+0.1%	+$228	0.02%	126
2026 Q1	$424K	Buy	19,799 +3,565	+22%	+$74.2K	0.02%	133
2025 Q4	$347K	Buy	16,234 +4,779	+42%	+$97.9K	0.01%	147
2025 Q3	$192K	Buy	+11,455	New	+$172K	0.01%	166
2020 Q2	–	Sell	-11,465	Closed	-$133K	–	218
2020 Q1	$133K	Sell	11,465 -36,028	-76%	-$743K	0.01%	183
2019 Q4	$1.32M	Buy	+47,493	New	+$1.19M	0.07%	114

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Seizert Capital Partners's MD Position: Q2 2026 in Review

Seizert Capital Partners increased its Pediatrix Medical (MD) stake by 0.05% in Q2 2026, buying an estimated $228 and bringing the position to 19,809 shares worth $502K. The position accounts for 0.02% of the portfolio, ranked #126.

Seizert Capital Partners first reported a position in MD in Q4 2019 and has held it in 6 quarters since. The position peaked at $1.32M in Q4 2019. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Seizert Capital Partners held 19,809 shares of Pediatrix Medical worth $502K as of Q2 2026.
Seizert Capital Partners bought 10 Pediatrix Medical shares in Q2 2026, an estimated $228.
Pediatrix Medical made up 0.02% of Seizert Capital Partners's portfolio in Q2 2026, its #126 holding.
Seizert Capital Partners first reported a position in Pediatrix Medical in Q4 2019 and has held it in 6 quarters since.
Seizert Capital Partners's Pediatrix Medical position peaked at $1.32M in Q4 2019.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Seizert Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.